395 related articles for article (PubMed ID: 30541581)
21. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
23. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
[TBL] [Abstract][Full Text] [Related]
24. Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy.
Hu X; Xu J; Wang W; Liu L; Jing Y; Gao C; Yu X; Li Y; Lin L; Tong J; Weng Q; Pan X; Zhang W; Ren H; Li G; Kiryluk K; Chen N; Xie J
Clin J Am Soc Nephrol; 2024 May; 19(5):573-582. PubMed ID: 38423528
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis.
Li W; Zhao Y
Int Urol Nephrol; 2019 Sep; 51(9):1581-1596. PubMed ID: 31140029
[TBL] [Abstract][Full Text] [Related]
26. Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
van de Logt AE; Dahan K; Rousseau A; van der Molen R; Debiec H; Ronco P; Wetzels J
Kidney Int; 2018 Apr; 93(4):1016-1017. PubMed ID: 29571438
[No Abstract] [Full Text] [Related]
27. Antibodies against M-Type Phospholipase A2 Receptor May Predict Treatment Response and Outcome in Membranous Nephropathy.
Qu Z; Zhang MF; Cui Z; Wang J; Wang M; Zhang YM; Wang F; Wang X; Meng LQ; Cheng XY; Liu G; Zhao MH
Am J Nephrol; 2018; 48(6):438-446. PubMed ID: 30472708
[TBL] [Abstract][Full Text] [Related]
28. Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy.
Netti GS; Infante B; Spadaccino F; Godeas G; Corallo MG; Prisciandaro C; Croce L; Rotondi M; Gesualdo L; Stallone G; Grandaliano G; Ranieri E
J Immunol Res; 2019; 2019():8483650. PubMed ID: 31781684
[TBL] [Abstract][Full Text] [Related]
29. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.
Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB
BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
32. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
[TBL] [Abstract][Full Text] [Related]
33. M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.
Hoxha E; Harendza S; Pinnschmidt H; Panzer U; Stahl RA
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1883-90. PubMed ID: 25267554
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacogenetic testing improves treatment responses in patients with PLA2R-related membranous nephropathy].
Tan T; Zheng Y; Li Y; Zeng Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):1047-1050. PubMed ID: 37439180
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
Oh YJ; Yang SH; Kim DK; Kang SW; Kim YS
PLoS One; 2013; 8(4):e62151. PubMed ID: 23637987
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.
Medrano AS; Escalante EJ; Cáceres CC; Pamplona IA; Allende MT; Terrades NR; Carmeno NV; Roldán EO; Agudelo KV; Vasquez JJ
Biomarkers; 2015 Feb; 20(1):77-83. PubMed ID: 25519165
[TBL] [Abstract][Full Text] [Related]
38. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
39. Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis.
Dong D; Fan TT; Wang YY; Zhang L; Song L; Zhang L
BMC Nephrol; 2019 Dec; 20(1):444. PubMed ID: 31791262
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
